KGK SCIENCE INC. – Trademark Portfolio
Entity Type: 03
KGK SCIENCE INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DIABETINOL, KGK SCIENCE, and KGK SYNERGIZE. The owner is based in LONDON, ONTARIO.
ONE LONDON PLACE, SUITE 1440, 255
QUEENS, AVENUE
LONDON, ONTARIO N6A 5R8 , CA
Showing of trademarks Trademarks
Trademark Classifications
KGK SCIENCE INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does KGK SCIENCE INC. have?
KGK SCIENCE INC. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.
What trademark classes does KGK SCIENCE INC. file in?
KGK SCIENCE INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 42 covers scientific and technological services; industrial analysis and research services.
What are KGK SCIENCE INC.'s most well-known trademarks?
KGK SCIENCE INC.'s registered trademark portfolio includes well-known marks such as DIABETINOL, KGK SCIENCE, and KGK SYNERGIZE. These are among 4 currently registered trademarks in the portfolio.
What is KGK SCIENCE INC.'s trademark registration success rate?
KGK SCIENCE INC. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.